A Clinical Study on TIL for the Treatment of Advanced Solid Tumors

Clinical trial NCT05087745 · RECRUITING

Trial details

NCT number: NCT05087745
Sponsor: Shanghai Juncell Therapeutics
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Tumor Infiltrating Lymphocytes Treatment Side Effects Effects of Immunotherapy

Start date: 2021-12-10
Primary completion: 2027-12-10
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.